Find insight on gold miners, Iluka Resources, South32 and more in the latest Market Talks covering basic materials.

MiNK Therapeutics (NASDAQ:INKT) stock fell 30% on Monday, paring a massive 730% gain from Friday after William Blair downgraded the shares following the spectacular rally.

The S&P/ASX 200 closed 9.7 points lower, down 0.11%. In a nutshell: ASX 200 followed US markets lower from Friday night Traders also digested Trump's weekend announcement of 30% tariffs on EU and ...